Abstract
Kawasaki disease can be associated with gastrointestinal complications, including pancreatitis. We describe a child in whom infliximab infusion for intravenous immunoglobulin-resistant Kawasaki disease coincided with marked clinical improvement of the patient's acute pancreatitis.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / administration & dosage*
-
Child
-
Female
-
Humans
-
Immunologic Factors / administration & dosage*
-
Infliximab
-
Infusions, Intravenous
-
Mucocutaneous Lymph Node Syndrome / complications*
-
Mucocutaneous Lymph Node Syndrome / drug therapy*
-
Pancreatitis / drug therapy*
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Immunologic Factors
-
Infliximab